Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

226 results about "Pharmaceutical Solutions" patented technology

Combination medicine for treating cancer

[Problem] To provide a novel combination medicine for treating cancer. [Solution] This combination medicine for treating cancer contains: a tyrosine kinase inhibitor; and Clostridium butyricum MIYAIRI 588 (FERM BP-2789) or a culture thereof.
Owner:MIYARISAN PHARMACEUTICAL CO LTD +1

Wearable device for treatments to enhance circulation in lower torso

A wearable device for treatments to enhance circulation in a lower torso. The device has a pouch assembly and a strap assembly with a waist belt and lateral straps. The strap assembly is secured around a body. The lateral straps, waist belt, and body create semi-sealed interfaces, forming a functional pocket between the pouch assembly and the body. The pouch assembly can be worn on the front or back of the body. The pouch assembly captures and retains fluids against the body, and allows physical access to the treatment area. With a continuous source of water, the semi-sealed nature of the pouch allows for water to circulate the treatment area. The materials are resistant to temperature, water, suds, human biowaste, and pharmaceutical solutions. The design's practicality and effectiveness in improving lower torso circulation are underscored by the strap assembly's secure fit and standing treatment orientation.
Owner:BROOKINS KEITH DONALD

Medicine solution preparation device

The utility model relates to the technical field of medicine solution preparation, and discloses a medicine solution preparation device which comprises a preparation equipment main body, a motor is fixedly connected to the top end of the preparation equipment main body, a transmission rod is fixedly connected to the bottom of the motor, and a mounting ring is in threaded connection with the surface of the transmission rod; the preparation equipment comprises a preparation equipment body, a sliding groove is formed in the preparation equipment body, a limiting hole is formed in the right end of the preparation equipment body, a workbench is slidably connected into the sliding groove, and a fixing ring is welded to the top of the workbench. By arranging the sliding limiting clamping rings and the pull rod in the fixing ring, the limiting handles on the left side and the right side can be matched with a worker to be matched with stretching and retracting of the spring, and the two limiting clamping rings slide left and right in the fixing ring; and a worker can conveniently place a medicament solution cup needing to be prepared between the two limiting clamping rings, so that the solution containing cup is limited and fixed.
Owner:NANJING XINYUAN PHARM TECH CO LTD

A pharmaceutical solution mixing device and operation method thereof

The present invention relates to the field of mixing technology, and specifically to a pharmaceutical solution mixing device and an operating method thereof, comprising a main cabinet, the main cabinet comprising two symmetrical cabinet cavities, the cabinet cavity being connected to a mixing box, the mixing box comprising: a stirring plate and a hinged plate at the bottom of the box; stirring plate tensioning bags are provided at both ends of the stirring plate, the stirring plate tensioning bags penetrate through the sealing connection with an opening and closing bolt, and the opening and closing bolt comprises an opening and closing bolt cap and an opening and closing bolt rod. The stirring plate of the present invention is driven by a power source motor to accelerate the mixing reaction of two pharmaceutical solutions by rotating the two pharmaceutical solutions. During the continuous rotation of the stirring plate, when the opening and closing bolt rod touches the hinged plate at the bottom of the box, the opening and closing bolt cap pushes away from the stirring plate tensioning bag to open it, allowing the catalyst inside it to enter the two pharmaceutical solutions, thereby accelerating the mixing reaction of the two pharmaceutical solutions. After the hinged plate at the bottom of the box is hit and rotated by the stirring plate, it rebounds to its original position, and the two pharmaceutical solutions are also stirred in the process.
Owner:上饶丁华化工中心(个人独资)

Medicine audit device, medicine packaging device, and medicine audit device

To accurately perform an audit of a medicine including a plurality of tablets.SOLUTION: A medicine audit device includes: a rotary disc 401 that rotates around a predetermined axis; a camera 501 that images a medicine placed on the rotating rotary disc 401; and an imaging / audit processing part that determines a type or the number of medicines imaged by the camera 501. In this case, for example, the camera 501 continuously images a plurality of medicine groups placed on the rotating rotary disc 401, and the imaging / audit processing part determines a type or the number of individual medicines in the medicine groups.SELECTED DRAWING: Figure 3
Owner:HITACHI CHANNEL SOLUTIONS CORP

How medical services are provided

We provide medical services that can ensure users have access to medications. [Solution] The control unit of the server terminal accepts from the user terminal a purchase request for a desired drug and online medical consultation from the drug and medical consultation menu presented on the platform site, accepts from the user terminal an online medical consultation request related to the desired drug and online medical consultation via the platform site, provides online medical consultation to the user terminal via a clinic terminal of a clinic affiliated with the operator of the platform site, calculates a fee for the clinic terminal based on the cost price of the desired drug and the price corresponding to the online medical consultation, and sends fee information related to the fee to the clinic terminal.
Owner:金田 卓也

Stable concentrated radiopharmaceutical compositions

To provide a radionuclide complex solution of high concentration and high chemical stability which can be used as a medicine for diagnosis and / or treatment.SOLUTION: Provided is a pharmaceutical composition comprising: (a) a complex formed by: (ai) a radionuclide; and (aii) a gastrin releasing peptide receptor peptide antagonist binding moiety linked to a chelating agent; (b) at least two stabilizers against radiolysis; and (c) optionally a surfactant.SELECTED DRAWING: None
Owner:NOVARTIS AG

Extracellular matrix modulating agent

To provide an agent for modulating expression of extracellular matrix by corneal endothelial cells.SOLUTION: The present invention pertains to an agent for modulating expression of extracellular matrix by corneal endothelial cells, containing 1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine or a salt thereof, or a solvate thereof.SELECTED DRAWING: None
Owner:クルーゼフリードリッヒ イー +2

A wastewater treatment agent mixing device for industrial wastewater treatment

This utility model discloses a wastewater treatment agent mixing device for industrial wastewater treatment, relating to the technical field of mixing devices. The device includes an assembly frame, a pharmaceutical tank, a tank lid, a stirring rod, a drive motor, a feeding pipe, and a discharging pipe. The device places a hollow cylinder between the stirring rod and the motor shaft of the drive motor, allowing an intelligent rotary nozzle connected to the hollow cylinder via an extension pipe to rotate circumferentially with the stirring rod. This uniformly feeds the pharmaceutical solution to various positions inside the pharmaceutical tank. A buffer plate reduces backsplashing of the solution, and the extension pipe, combined with an auxiliary scraper, scrapes away any precipitated pharmaceutical solution adhering to the inner wall and bottom surface of the pharmaceutical tank, achieving rapid and thorough mixing of the solution with water and other substances.
Owner:DALIAN UNIV OF TECH ENVIRONMENT ENG RES & DESIGN INSTIT UTE

Therapeutic agent for autism spectrum disorder

To provide a more effective medicine for treating ASD.SOLUTION: A therapeutic agent for autism spectrum disorder, comprising an oxytocin receptor agonist as an active ingredient, wherein the therapeutic agent is administered in combination with a vasopressin 1a receptor antagonist. A therapeutic agent for autism spectrum disorder, comprising an oxytocin receptor agonist as an active ingredient, wherein the therapeutic agent is administered in combination with a vasopressin 30IU receptor antagonist. A therapeutic agent for autism spectrum disorder, wherein the oxytocin-receptor agonist is not agonistic to the vasopressin 1a receptor; a pharmaceutical composition for the treatment of autism spectrum disorder, wherein the pharmaceutical composition comprises an oxytocin-receptor agonist and a vasopressin 1a receptor antagonist as active ingredients; a pharmaceutical composition for the treatment of autism spectrum disorder, wherein the oxytocin-receptor agonist is not agonistic to the vasopressin 30IU receptor; and a pharmaceutical composition for the treatment of autism spectrum disorder, wherein the vasopressin-receptor antagonist is SR49059. 1a.SELECTED DRAWING: None
Owner:HAMAMATSU UNIV SCHOOL OF MEDICINE

Pharmaceutical composition

The object of the present invention is to provide an active ingredient for a systemically administered mRNA pharmaceutical that expresses an antibody specific to the V antigen protein or its homologous protein of Gram-negative bacteria, and a systemically administered mRNA pharmaceutical using the same. [Solution] mRNA containing an antibody coding region encoding a specific scFv antibody against the V antigen protein or its homologous protein of pathogenic Gram-negative bacteria is useful as an active ingredient in mRNA pharmaceuticals for systemic administration.
Owner:KYOTO PREFECTURAL PUBLIC UNIV CORP

Therapeutic agent for PARP inhibitor-resistant cancer

To provide a therapeutic agent for PARP inhibitor-resistant cancer.SOLUTION: The present invention relates to a pharmaceutical composition for treating or preventing a solid cancer patient having resistance to a PARP inhibitor, and the pharmaceutical composition according to the present invention can effectively reduce the size of a tumor in a patient having resistance to a PARP inhibitor.SELECTED DRAWING: Figure 4
Owner:ONCONIC THERAPEUTICS INC

Epoxy resin production refining kettle

The utility model discloses an epoxy resin production refining kettle which comprises a kettle body, a blanking funnel is fixedly connected to the bottom end of the kettle body, a blanking port is formed in the lower end of the middle of the blanking funnel in a penetrating mode, a feeding pipe is embedded in one side of the top end of the kettle body, a motor is fixedly connected to the middle of the top end of the kettle body, and the output end of the motor is fixedly connected with a driving rod. A plurality of stirring rods are fixedly connected to the lower end of the rod wall of the driving rod, a plurality of turning rods are fixedly connected to the upper end of the rod wall of the driving rod, rotating rings are fixedly connected to the tops, close to the outer ends, of the turning rods, and a plurality of L-shaped scraping plates are fixedly connected to the bottom ends of the rotating rings; the inner side wall of the bearing is fixedly connected with the rotating ring, the lower end of the outer wall of the kettle body is fixedly connected with a mounting ring, and the lower end of the mounting ring is fixedly connected with a plurality of supporting legs, so that the inner wall of the kettle body can be scraped and cleaned, and a large amount of liquid medicine is prevented from remaining on the inner wall of the kettle body to influence next use.
Owner:ZHEJIANG HAOBANG CHEM

Methods for manufacturing refined pharmaceutical solutions

A method for manufacturing a refined pharmaceutical solution used in the manufacture of semiconductor devices is provided, which refines the crude pharmaceutical solution by removing minute foreign matter through filtration using a porous membrane. In the manufacture of the refined pharmaceutical solution used in the manufacture of semiconductor devices, a porous polyamide membrane is used as a filter to filter the crude pharmaceutical solution. The aforementioned porous polyamide membrane has a plurality of spherical pores inside, and the plurality of spherical pores are connected to adjacent spherical pores to form interconnected pores.
Owner:TOKYO OHKA KOGYO CO LTD

Pharmaceutical solution composition and oral mist inhaler comprising the same

To provide a pharmaceutical solution composition and an oral mist inhaler comprising the same.SOLUTION: A pharmaceutical solution composition provided by the present invention includes a therapeutically effective amount of molnupiravir or a metabolite thereof and a solvent. An oral mist inhaler further provided by the present invention includes a soft mist inhaler and the above pharmaceutical solution composition loaded in the soft mist inhaler. The pharmaceutical solution composition of the present invention has high stability and generates a relatively small amount of impurities. The oral mist inhaler provided by the present invention allows a user to directly inhale the above pharmaceutical solution composition, so that the composition can be rapidly absorbed and the metabolic process of the drug in the body is reduced, thereby significantly improving the bioavailability of the drug. The particles formed by atomizing the composition are extremely small, and a large amount of mist is sprayed. Compared with a conventional oral administration method, the oral mist inhaler of the present invention is easy to use and can improve comfort and convenience during medicine consumption for a user.SELECTED DRAWING: Figure 4
Owner:CHINA CHEM & PHARM CO LTD

Device for preparing and transferring sterile liquid medicine

According to the device for preparing and transferring the sterile liquid medicine, a preparation assembly is used for preparation and sterile treatment of auxiliary materials of the sterile liquid medicine, and the preparation assembly is arranged in a non-sterile environment; the first batching tank is used for preparing main raw materials of the sterile liquid medicine, is arranged in a sterile environment and is connected with the preparation assembly; the second batching tank is movably arranged in a non-sterile environment, the interior of the second batching tank is in a sterile state, and the second batching tank is connected with the first batching tank; the power source device can generate power, so that the sterile liquid medicine auxiliary materials enter the first batching tank after being subjected to configuration and sterile treatment, and carry the sterile liquid medicine main raw materials in the first batching tank to enter the second batching tank; the second mixing tank can be moved to a position close to the filling line and is in sterile butt joint with the filling line. According to the device, continuous supply of materials among different clean environments can be ensured, meanwhile, flexible matching in the sterile liquid medicine preparation process is achieved, and the sterility of the materials can be kept.
Owner:OCUMENSION THERAPEUTICS (SUZHOU) CO LTD

Combination therapy of arms and natural killer cells

To provide medicines comprising immune cells and antibody-recruiting molecules.SOLUTION: The present invention provides a medicine comprising a plurality of natural killer cells and / or an antibody-recruiting molecule (ARM), for inducing cell death of cancer cells in a subject, inhibiting cancer cell growth and / or reducing the number of cancer cells.SELECTED DRAWING: None
Owner:KLEO PHARMACEUTICALS INC

Spoon for medication and medication method

To provide a spoon for medication capable of wrapping powder medicine with semisolid food such as ice cream and providing it to a patient.SOLUTION: The spoon 1 for medication for wrapping the medicine P with the semisolid food C and providing it to the patient is provided with a spoon 2 for placing the semisolid food C and a molding processing part 7 for molding a recess Ch for charging the medicine P to the semisolid food C. The molding processing part 7 includes a pedestal 10 covering the outer periphery of the spatula 4 of the spoon 2 and forming a space S for arranging the semisolid food C on the upper surface of the spatula 4, a top cover 20 covering the upper surface of the pedestal 10, and a boring plug 30 fitted into an insertion hole 22 formed in the top cover 20.SELECTED DRAWING: Figure 1
Owner:PREMM LLC +1

Coronavirus killing agent

PendingJP2026031579ABiocideChloritesDisinfectantChlorous acid
To provide a coronavirus killing agent.SOLUTION: The present disclosure provides coronavirus killing agents. In particular, the present disclosure provides a coronavirus disinfectant comprising a chlorous acid aqueous solution. In particular, the present disclosure provides a method for killing or disinfecting coronavirus using a chlorous acid aqueous solution. The concentration of free chlorine (assuming Cl = 35.45) in a chlorous acid aqueous solution can be at least 5ppm or higher in the absence of organic matter. The content of chlorous acid in the chlorous acid aqueous solution (HClO2 = 68.46) can be at least 200ppm or more under the presence of organic matter including disinfection of hands and the like. The coronavirus may be SARS coronavirus (SARS-CoV), MERS coronavirus (MERS-CoV), or 2019 novel coronavirus (SARS-CoV-2).SELECTED DRAWING: None
Owner:三庆株式会社

Industrial sewage treatment equipment and treatment method thereof

The invention discloses industrial sewage treatment equipment and a treatment method thereof, and belongs to the field of sewage treatment.The industrial sewage treatment equipment comprises a sewage treatment equipment body, and a liquid medicine preparation cylinder is fixedly installed outside the sewage treatment equipment body; after signal data of the pollution index measuring device is received through the assembly controller, the specific dosage of solid agent particles and liquid is controlled, the quality of a prepared solution is effectively improved, then the purification quality of sewage is improved, the index of the sewage is monitored in real time through the pollution index measuring device, and the sewage treatment efficiency is improved. The specific preparation proportion of the liquid medicine is adjusted according to the monitoring result, through cooperative use of the flexible storage bag and the lower sealing strip, the accuracy of the preparation amount of solid medicine particles is effectively improved, then the sewage treatment effect of the prepared liquid medicine is effectively improved, meanwhile, the medicine waste is effectively reduced through accurate dosage preparation, and the cost is reduced. And secondary pollution caused by excessive chemicals is effectively avoided.
Owner:钟园

Drug supply unit and substrate processing system thereunder, and drug supply method thereof

ActiveCN116266546BEliminate the risk of process accidentseliminate dangerLaboratory glasswaresOptically investigating flaws/contaminationChemical reactionDrug supply
This invention relates to a pharmaceutical supply unit and a substrate processing system thereunder, as well as a pharmaceutical supply method. It discloses a technique for ensuring the reliability and stability of the process by sensing and removing impurities generated during a chemical reaction when a pharmaceutical solution is supplied through the pharmaceutical supply unit.
Owner:SYSTEM ENGINEERING MEGA SOLUTION CO LTD

Method and drug for treating viral pneumonia

To provide a method and a drug for treating viral pneumonia.SOLUTION: A pharmaceutical composition comprises a therapeutically effective amount of one or more compounds selected from the group consisting of a component of plasminogen activation pathway, a compound capable of activating plasminogen, a compound mimicking the activity of plasminogen or plasmin, a compound capable of upregulating the expression of plasminogen or an activator of plasminogen, an analog of plasminogen, an analog of plasmin, an analog of tPA or uPA, and an antagonist of fibrinolysis inhibitor.SELECTED DRAWING: None
Owner:TALENGEN INTERNATIONAL LIMITED

Drawer direction control system for drug distribution cart

To provide a drug distribution cart that enables stored medications to be taken out by pulling out a storage unit (drawer) in a first direction and by pulling it out in a second, opposite direction.SOLUTION: Medications to be provided to a user are stored in a drug distribution cart. The drug distribution cart, which includes a storage unit (drawer), enables the stored medications to be taken out by pulling out the drawer in a first direction or in a second direction opposite to the first.SELECTED DRAWING: Figure 1
Owner:THE CHUGOKU ELECTRIC POWER CO INC

Agent for treatment of cancer, and pharmaceutical composition containing the same

To provide an agent for the treatment of cancer, in particular, an agent which can be used in combination with boron neutron capture therapy and photodynamic therapy for the treatment of cancer.SOLUTION: The foregoing problem is solved by providing an agent for the treatment of cancer, the agent containing: a carrier that is accumulating in cancer cells; and a boron-containing compound and / or a photosensitizer covalently bonded and / or non-covalently bonded to the carrier, and the agent being used for cancer therapy in which a subject administered with the agent is irradiated with radiation.SELECTED DRAWING: Figure 21
Owner:UNIV OKAYAMA +1